<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="122590">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01771172</url>
  </required_header>
  <id_info>
    <org_study_id>ASQ</org_study_id>
    <nct_id>NCT01771172</nct_id>
  </id_info>
  <brief_title>Acute Subcutaneous Defibrillation</brief_title>
  <acronym>ASQ</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiac Rhythm Disease Management</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiac Rhythm Disease Management</source>
  <oversight_info>
    <authority>Serbia and Montenegro: Agency for Drugs and Medicinal Devices</authority>
    <authority>Slovakia: State Institute for Drug Control</authority>
    <authority>Denmark: Danish Medicines Agency</authority>
    <authority>United Kingdom: Medicines and Healthcare Products Regulatory Agency</authority>
    <authority>Netherlands: Ministry of Health, Welfare and Sport</authority>
    <authority>Belarus: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the defibrillation efficacy of a subcutaneous defibrillation system.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Subjects will demonstrate a successful defibrillation outcome if they have 2 successful defibrillation shocks with the research system.</measure>
    <time_frame>within the first day</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Ventricular Arrhythmias</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects may be either male or female, and must meet all of the inclusion criteria and
        none of the exclusion criteria of the study
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must be undergoing implant of a commercially approved ICD system

          -  Subject must be willing to provide Informed Consent

          -  Subject must be &gt; 18 years old

        Exclusion Criteria:

          -  Subject with impaired kidney function as measured by a glomerular filtration rate
             (eGFR) estimate &lt; 29 mls/min/1.73m2 (recorded in the last six months)

          -  Subject has high risk of infection

          -  Subject has EF &lt; 15%

          -  Subject at high risk of stroke

          -  having a device replacement

          -  Subject with an implanted active non-ICD device, cardiac or non-cardiac (e.g., Neuro
             stimulator, Pacemaker)

          -  Subject is indicated for CRT

          -  Subject is pacemaker dependent

          -  Subject enrolled in a concurrent study that may confound the results of this study

          -  Subject has medical conditions that would limit study participation

          -  Subject is pregnant

          -  Subject meets exclusion criteria required by local law (e.g. age, breast feeding,
             etc.)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>ASQ Clinical Trial Leader Wood</last_name>
    <phone>18006338766</phone>
    <email>medtronicCRMtrials@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Slovak Medical University</name>
      <address>
        <city>Bratislava</city>
        <zip>83348</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Slovakia</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 16, 2013</lastchanged_date>
  <firstreceived_date>January 16, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
